Schrodinger, Inc.

SDGR Healthcare Health Information Services

Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.

Revenue
+18.7%
EPS
−11.1%
Free cash flow
+21.6%

Quarter to September 2026, against a year earlier

29.96 1.19 +4.14%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−16.5×
Dividend yield
—
F-score
5/9
Altman Z
1.10
Beneish M
−3.47
Dividend safety
n/a

Schrodinger, Inc. (SDGR) P/E ratio

Alert me on P/E ratio

Schrodinger, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 253× (June 2023) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 61.3× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
27 more quarters

Against its own ten years

Low 0.0× High 253×
Ten-year median 0.0×
Current reading's percentile 85

P/E ratio against peers

Company P/E ratio
CERT Certara, Inc. compare n/m
HTFL Heartflow, Inc. compare n/m
SDGR Schrodinger, Inc. n/m
TDOC Teladoc Health, Inc. compare n/m
OMCL Omnicell, Inc. compare 39.0×
HSTM HealthStream, Inc. compare 42.0×
GDRX GoodRx Holdings, Inc. compare 65.7×
PRVA Privia Health Group, Inc. compare 88.3×
OMDA Omada Health, Inc. compare 267×
Health Information Services industry median 42.0×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on SDGR